← back to search

Christopher S. Nabel

Massachusetts Institute of Technology · US
Area of research
Molecular Biology · Oncology
Research interest
Research interests include Biology, Medicine, Histopathology, Pathology, Disease, and Internal medicine.
h-index
citations
1,803
works
9
NIH funding
primary concept
email

Recent publications

Human lung cancer harbors spatially organized stem-immunity hubs associated with response to immunotherapy
Nature Immunology 2024cited by 123position: middledoi
Unprocessed genomic uracil as a source of DNA replication stress in cancer cells
Molecular Cell 2024cited by 36position: middledoi
Metabolite profiling of human renal cell carcinoma reveals tissue-origin dominance in nutrient availability
eLife 2024cited by 16position: middledoi
Nucleotide imbalance decouples cell growth from cell proliferation
Nature Cell Biology 2022cited by 208position: middledoi
Discovery and validation of a novel subgroup and therapeutic target in idiopathic multicentric Castleman disease
Blood Advances 2021cited by 47position: middledoi
Identification of DHODH as a therapeutic target in small cell lung cancer
Science Translational Medicine 2019cited by 140position: middledoi
International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman disease
Blood 2017cited by 611position: middledoi
Idiopathic multicentric Castleman's disease: a systematic literature review
The Lancet Haematology 2016cited by 320position: middledoi
AID/APOBEC deaminases disfavor modified cytosines implicated in DNA demethylation
Nature Chemical Biology 2012cited by 302position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Matthew G. Vander Heiden · Broad Institute4 papers (2019–2024)Caroline A. Lewis · University of Massachusetts Chan Medical School3 papers (2019–2024)Frits van Rhee · Winthrop Rockefeller Foundation2 papers (2016–2021)David C. Fajgenbaum · Penn Center for AIDS Research2 papers (2016–2021) · 2 papers (2016–2021)Alicia M. Darnell · Massachusetts Institute of Technology1 papers (2022–2022)Caroline R. Crosby · Massachusetts Institute of Technology1 papers (2024–2024)Bradley I. Reinfeld · Vanderbilt University Medical Center1 papers (2024–2024) · 1 papers (2021–2021)Michael E. Weinblatt · Brigham and Women's Hospital1 papers (2021–2021)Johnathan R. Kent · University of Chicago1 papers (2024–2024)Kirsten Young · Vanderbilt University Medical Center1 papers (2024–2024)Maria Lucia L. Madariaga · University of Chicago1 papers (2024–2024)Peggy P. Hsu · Massachusetts Institute of Technology1 papers (2019–2019)Eugene Oh · Harvard University1 papers (2024–2024)Razelle Kurzrock · Froedtert Hospital1 papers (2016–2016)Sushila Shenoy · Medidata (United States)1 papers (2021–2021)Amy Deik · Broad Institute1 papers (2024–2024)Nicholas J. Dyson · Center for Cancer Research1 papers (2019–2019)Alexander Fosså · University of Oslo1 papers (2021–2021)